A carregar...
Atezolizumab, a PD-L1 Inhibitor: An Association of Bleeding Gastric Ulcer With Its Use
Atezolizumab is a programmed death-ligand 1 inhibitor, an immune checkpoint inhibitor (ICI), useful in various advanced solid malignancies. As atezolizumab is more commonly used nowadays, physicians should be aware of the rare associated adverse events (AEs). Most of the AEs associated with the ICIs...
Na minha lista:
| Publicado no: | Cureus |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cureus
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8208334/ https://ncbi.nlm.nih.gov/pubmed/34150414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.15637 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|